Skip to main content
Fig. 2 | BMC Cancer

Fig. 2

From: A small molecular agent YL529 inhibits VEGF-D-induced lymphangiogenesis and metastasis in preclinical tumor models in addition to its known antitumor activities

Fig. 2

The effects of YL529 on HLECs. a Wound assay. Cells were wounded and migrated cells were quantified by manual counting; b Transwells assay. Invaded cells were stained and quantified; c Tube formation assay. 100×, Mean ± SEM, n = 3, *p < 0.05, **p < 0.01, ***p < 0.001

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us